Medroxyprogesterone acetate - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA (10.10.24)

Notice type: 3rd Party Publications

Date: 11/10/2024




Problem Or Issue:

Important Safety Information from Pfizer Healthcare Ireland regarding Medroxyprogesterone acetate: Risk of meningioma and measures to minimise this risk

 

Important Safety Information – Medroxyprogesterone acetate


« Back